Jco精准肿瘤学 SCIE

期刊简介预计审稿时间：

JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Innovative and timely scientific and educational content provide a deeper understanding of actionable cancer genomics, personalized translational and clinical oncology research, and recent treatment advances based on tumor molecular profiling. The scope of publications includes all types of clinical research (basket trials, exceptional response results, informatics, computational approaches, mechanism and evidence-based case reports and small series of educational value), and extensive expert driven commentary, editorials and reviews considering the challenges and value of targeted therapies based on genomic analyses. JCO PO is published by the American Society of Clinical Oncology (ASCO).

JCO PO 是一本同行评审的在线文章型期刊，发表原创研究、报告、观点和评论，推动精准肿瘤学的科学和实践，并定义癌症患者的基因组学和其他生物标志物驱动的临床护理。创新且及时的科学和教育内容提供了对可操作的癌症基因组学、个性化转化和临床肿瘤学研究以及基于肿瘤分子分析的最新治疗进展的更深入了解。出版物范围包括所有类型的临床研究（篮子试验、特殊反应结果、信息学、计算方法、机制和循证病例报告以及具有教育价值的小系列），以及大量专家驱动的评论、社论和评论，考虑到基于基因组分析的靶向治疗的挑战和价值。 JCO PO 由美国临床肿瘤学会 (ASCO) 出版。

《Jco Precision Oncology》(Jco精准肿瘤学)编辑部通讯方式为TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。